Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

The Prostate

Showing results (651-660 of 6,084) with videos related to

Pageof 609
Sort By:
The Prostate|January 13, 2004
Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell lineC B Lazier, L N Thomas, R C Douglas, et al.
The Prostate|January 13, 2004
Radioimmunotherapy of prostate cancer in human xenografts using monoclonal antibodies specific to prostate specific membrane antigen (PSMA): studies in nude miceShankar Vallabhajosula, Peter M Smith-Jones, Vincent Navarro, et al.
The Prostate|October 20, 2007
Dominance of CD4+ lymphocytic infiltrates with disturbed effector cell characteristics in the tumor microenvironment of prostate carcinomaKathleen Ebelt, Gregor Babaryka, Ainhoa M Figel, et al.
The Prostate|November 14, 2007
Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axisStephen J Freedland, John Mavropoulos, Amy Wang, et al.
The Prostate|November 17, 2007
Involvement of decreased Galectin-3 expression in the pathogenesis and progression of prostate cancerAxel S Merseburger, Mario W Kramer, Jörg Hennenlotter, et al.
The Prostate|October 12, 2007
High expression of PSM-E correlated with tumor grade in prostate cancer: a new alternatively spliced variant of prostate-specific membrane antigenKai-Yuan Cao, Xiao-Peng Mao, Dao-Hu Wang, et al.
The Prostate|October 16, 2007
Prostate cancer cells tolerate a narrow range of androgen receptor expression and activityNatalia D Tararova, Natalya Narizhneva, Vadim Krivokrisenko, et al.
The Prostate|September 25, 2008
High frequency of prostate antigen-directed T cells in cancer patients compared to healthy age-matched individualsOle Forsberg, Björn Carlsson, Per-Uno Malmström, et al.
The Prostate|September 27, 2008
The accumulation of versican in the nodules of benign prostatic hyperplasiaLawrence D True, Sarah Hawley, Thomas H Norwood, et al.
The Prostate|October 14, 2008
Transition zone and anterior stromal prostate cancers: zone of origin and intraprostatic patterns of spread at histopathologySébastien Bouyé, Eric Potiron, Philippe Puech, et al.
Pageof 609

Showing results (651-660 of 6,084) with videos related to

Sort By:
Pageof 609
The Prostate|January 13, 2004
Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell lineC B Lazier, L N Thomas, R C Douglas, et al.
The Prostate|January 13, 2004
Radioimmunotherapy of prostate cancer in human xenografts using monoclonal antibodies specific to prostate specific membrane antigen (PSMA): studies in nude miceShankar Vallabhajosula, Peter M Smith-Jones, Vincent Navarro, et al.
The Prostate|October 20, 2007
Dominance of CD4+ lymphocytic infiltrates with disturbed effector cell characteristics in the tumor microenvironment of prostate carcinomaKathleen Ebelt, Gregor Babaryka, Ainhoa M Figel, et al.
The Prostate|November 14, 2007
Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axisStephen J Freedland, John Mavropoulos, Amy Wang, et al.
The Prostate|November 17, 2007
Involvement of decreased Galectin-3 expression in the pathogenesis and progression of prostate cancerAxel S Merseburger, Mario W Kramer, Jörg Hennenlotter, et al.
The Prostate|October 12, 2007
High expression of PSM-E correlated with tumor grade in prostate cancer: a new alternatively spliced variant of prostate-specific membrane antigenKai-Yuan Cao, Xiao-Peng Mao, Dao-Hu Wang, et al.
The Prostate|October 16, 2007
Prostate cancer cells tolerate a narrow range of androgen receptor expression and activityNatalia D Tararova, Natalya Narizhneva, Vadim Krivokrisenko, et al.
The Prostate|September 25, 2008
High frequency of prostate antigen-directed T cells in cancer patients compared to healthy age-matched individualsOle Forsberg, Björn Carlsson, Per-Uno Malmström, et al.
The Prostate|September 27, 2008
The accumulation of versican in the nodules of benign prostatic hyperplasiaLawrence D True, Sarah Hawley, Thomas H Norwood, et al.
The Prostate|October 14, 2008
Transition zone and anterior stromal prostate cancers: zone of origin and intraprostatic patterns of spread at histopathologySébastien Bouyé, Eric Potiron, Philippe Puech, et al.
Pageof 609